Opus Genetics IRD Cash received from option exercises
Cash received from option exercises at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's cash received from option exercises.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's cash received from option exercises?
- Opus Genetics (IRD) reported cash received from option exercises of $738K in Q1 2026.
- How has Opus Genetics's cash received from option exercises changed year-over-year?
- Opus Genetics's cash received from option exercises increased by 14660.0% year-over-year, from $5K to $738K.
- What is the long-term trend for Opus Genetics's cash received from option exercises?
- Over 3 years (2021 to 2025), Opus Genetics's cash received from option exercises has grown at a 59.3% compound annual growth rate (CAGR), from $87K to $352K.
- What does cash received from option exercises mean?
- The total cash proceeds received from employees or directors exercising their vested stock options. This serves as an indicator of employee participation in equity incentive plans and provides a source of non-dilutive capital.